Conversely, upregulation of the transforming growth factor-beta (TGF-β) signaling pathways, such as those involving activin A and ALK1, has been implicated as a complementary mechanism driving vascular remodeling in PAH. This evidence concerns the gene TGFB1 and pulmonary arterial hypertension.